215 First Street, 3rd Floor
About Relay Therapeutics
Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities.
CSO and Co-Founder: Mark Murcko, Ph.D.
CEO: Sanjiv Patel
VP, Corporate Development and Strategy: Deborah Palestrant
7 articles with Relay Therapeutics
Based in Cambridge, MA and founded in February 2016, Relay Therapeutics focuses on developing therapeutics based on protein motion.
BioSpace is proud to present its NextGen "Class of 2018," a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.
The round was led by BVF Partners, with new investors GV, Casdin Capital, EcoR1 Capital and Section 32.
O’Brien joins Relay Therapeutics with significant strategic human resources experience in the life sciences industry.
Relay Therapeutics Names Deborah Palestrant, Ph.D., Vice President Of Corporate Development And Strategy